Telomir Pharmaceuticals, Inc. (TELO)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.42
- As of
Kresmion compiles this page from TELO's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Telomir Pharmaceuticals, Inc. (TELO): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-06.
See the full TELO dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for TELO on one page. Preview it with sample data, then open it live with a free account.
Preview the TELO dossierActive events for TELO
- medium13F: new position
CITADEL ADVISORS LLC new position in TELO
- mediumEarnings above estimates
Q1-2025: Beat consensus by 31.4% - EPS $-0.07 vs $-0.102 estimate
- mediumEarnings above estimates
Q3-2025: Beat consensus by 58.0% - EPS $-0.03 vs $-0.0714 estimate
- mediumEarnings above estimates
Beat consensus by 31.4% - EPS $-0.07 vs $-0.102 estimate
- mediumEarnings below estimates
Q2-2025: Missed consensus by 108.3% - EPS $-0.17 vs $-0.0816 estimate
FREE, NO ACCOUNT
Every event on TELO, as it fires
You are seeing 5 of 7 events recorded on TELO since 2026-05-30.
The five above landed across 3 days. The other 2 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, TELO
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
TELO's 10-Q filed Nov 6, 2026 states:
These factors raise substantial doubt about the Company's ability to continue as a going concern for a period of twelve months from the issuance date of this Report.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on TELO
Cite this data
Kresmion counts the managers it follows that reported a non-option position in TELO on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on TELO in the last 180 days.
Upstream: SEC EDGAR filings for TELO
Kresmion, "Telomir Pharmaceuticals, Inc. (TELO) institutional holdings and SEC filings", data as of 2026-11-06, https://kresmion.com/research/TELO. Upstream data: SEC EDGAR filings for TELO.
Link to this data (HTML):
<a href="https://kresmion.com/research/TELO">Telomir Pharmaceuticals, Inc. (TELO) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow TELO on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to TELO for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.